Founded

Address

BioCrossroads
300 N. Meridian Street
Suite 950
Indianapolis, IN 46204
United States

Open map

Tags
KANDO id: 23926

Corporate information

Registration country

Funds managed

Fund Type Vintage Currency Committed capital
Indiana Future Fund I 2003 USD 73,000,000
INext Fund USD 58,000,000
Indiana Seed Fund Venture USD 6,000,000
Indiana 21st Century Research and Technology Fund Venture USD 233,000,000

Funding rounds


Investment activity status
Active investor

Selected investments

Displaying 1 - 1 of 1
Profile Country Funding
CoLucid Pharmaceuticals Biopharmaceutical company developing therapeutics to treat neurological dysfunctions. N/A

Financials